Literature DB >> 25977400

Non-susceptibility to ceftaroline in healthcare-associated multiresistant MRSA in Eastern Australia.

Nasmiya Mubarak1, Indy Sandaradura2, Lupeoletalalelei Isaia3, Matthew O'Sullivan3, Fei Zhou4, Deborah Marriott5, Jon R Iredell6, John Harkness2, David Andresen7.   

Abstract

Entities:  

Keywords:  ST239-III; epidemiology; methicillin-resistant Staphylococcus aureus; resistance; surveillance

Mesh：

Substances：

Year:  2015        PMID： 25977400     DOI： 10.1093/jac/dkv124

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  3 in total

1.  Reduced In Vitro Activity of Ceftaroline by Etest among Clonal Complex 239 Methicillin-Resistant Staphylococcus aureus Clinical Strains from Australia.

Authors:  I J Abbott; A W J Jenney; C J Jeremiah; M Mirčeta; J P Kandiah; D C Holt; S Y C Tong; D W Spelman
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

Review 2.  Antimicrobial resistance in methicillin-resistant Staphylococcus aureus to newer antimicrobial agents.

Authors:  Richard R Watkins; Marisa Holubar; Michael Z David
Journal:  Antimicrob Agents Chemother       Date:  2019-09-16       Impact factor: 5.191

3.  Evaluation of in vitro activity of ceftaroline on methicillin resistant Staphylococcus aureus blood isolates from Iran.

Authors:  Negin Abdizadeh; Mehri Haeili; Hossein Samadi Kafil; Amin Ahmadi; Mohammad Mehdi Feizabadi
Journal:  Iran J Microbiol       Date:  2021-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.